BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19553817)

  • 1. Predicting life expectancy in prostate cancer patients.
    Jeldres C; Latouff JB; Saad F
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):166-9. PubMed ID: 19553817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
    Walz J; Gallina A; Perrotte P; Jeldres C; Trinh QD; Hutterer GC; Traumann M; Ramirez A; Shariat SF; McCormack M; Perreault JP; Bénard F; Valiquette L; Saad F; Karakiewicz PI
    BJU Int; 2007 Dec; 100(6):1254-8. PubMed ID: 17979925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
    Walz J; Gallina A; Hutterer G; Perrotte P; Shariat SF; Graefen M; McCormack M; Bénard F; Valiquette L; Saad F; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):88-94. PubMed ID: 17446004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting life expectancy in men with clinically localized prostate cancer.
    Cowen ME; Halasyamani LK; Kattan MW
    J Urol; 2006 Jan; 175(1):99-103. PubMed ID: 16406881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inventory of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
    Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
    Walz J; Suardi N; Shariat SF; Jeldres C; Perrotte P; Graefen M; Widmer H; Arjane P; Valiquette L; Hutterer G; Saad F; Karakiewicz PI
    BJU Int; 2008 Jul; 102(1):33-8. PubMed ID: 18384631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
    Shariat SF; Karakiewicz PI; Suardi N; Kattan MW
    Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
    Nguyen CT; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a clinical prediction model to calculate patient life expectancy: the measure of actuarial life expectancy (MALE).
    Clarke MG; Kennedy KP; MacDonagh RP
    Med Decis Making; 2009; 29(2):239-46. PubMed ID: 19047762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer.
    Hall WH; Jani AB; Ryu JK; Narayan S; Vijayakumar S
    Prostate Cancer Prostatic Dis; 2005; 8(1):22-30. PubMed ID: 15700051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of patient life-expectancy: how accurate are urologists and oncologists?
    Wilson JR; Clarke MG; Ewings P; Graham JD; MacDonagh R
    BJU Int; 2005 Apr; 95(6):794-8. PubMed ID: 15794785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.
    Sammon JD; Abdollah F; D'Amico A; Gettman M; Haese A; Suardi N; Vickers A; Trinh QD
    Eur Urol; 2015 Nov; 68(5):756-65. PubMed ID: 25819724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and statistical methods in prediction of patient outcome.
    Bostwick DG; Adolfsson J; Burke HB; Damber JE; Huland H; Pavone-Macaluso M; Waters DJ
    Scand J Urol Nephrol Suppl; 2005 May; (216):94-110. PubMed ID: 16019761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
    Nguyen CT; Zelefsky MJ; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of localized prostate cancer in senior adults: the crucial role of comorbidity.
    Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 2():16-22. PubMed ID: 18307688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting cancer-control outcomes in patients with renal cell carcinoma.
    Isbarn H; Karakiewicz PI
    Curr Opin Urol; 2009 May; 19(3):247-57. PubMed ID: 19325492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.
    Valdagni R; Rancati T; Fiorino C
    Cancer; 2009 Jul; 115(13 Suppl):3141-9. PubMed ID: 19544543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer nomograms: an update.
    Chun FK; Karakiewicz PI; Briganti A; Gallina A; Kattan MW; Montorsi F; Huland H; Graefen M
    Eur Urol; 2006 Nov; 50(5):914-26; discussion 926. PubMed ID: 16935414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based medicine in prostate cancer: where do we stand in 2006?
    Dahm P
    Curr Opin Urol; 2006 May; 16(3):162-7. PubMed ID: 16679853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.